Search filters

List of works by Martín Estrada

3-Amidocoumarins as Potential Multifunctional Agents against Neurodegenerative Diseases

scientific article published on 23 October 2015

Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin

scientific article

Multi-target-directed ligands for Alzheimer's disease: Discovery of chromone-based monoamine oxidase/cholinesterase inhibitors

scholarly article by Joana Reis et al published October 2018 in European Journal of Medicinal Chemistry

Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease

scientific article published on 11 July 2018

New cinnamic - N-benzylpiperidine and cinnamic - N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties

scientific article published on 25 May 2016

New flavonoid – N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties

scientific article published on 01 December 2019

PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice

scientific article published on 13 June 2013

Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives

scientific article published on 08 December 2014

Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: Synthesis, biological assessment, and molecular modeling ⬇️

scientific article published on September 29, 2012

Recent Advances in Neurogenic Small Molecules as Innovative Treatments for Neurodegenerative Diseases

scientific article

Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades

scientific article published on 04 March 2022

Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties

scientific article published on 25 January 2020

Paulina is supported by:

About Paulina

Help